RISARG Trademark

Trademark Overview

On Friday, June 30, 2006, a trademark application was filed for RISARG with the United States Patent and Trademark Office. The USPTO has given the RISARG trademark a serial number of 79026625. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, April 6, 2016. This trademark is owned by NOVARTIS AG. The RISARG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and/or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, the genitourinary system, musculo-skeletal and inflammatory disorders; or used in dermatology, oncology, hematology, opthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; pharmaceutical preparations for the treatment of bacteria-based diseases; anti-infectives, antivirals, antibiotics, antifungals, vaccines, and pharmaceutical preparations for diagnostic use
risarg

General Information

Serial Number79026625
Word MarkRISARG
Filing DateFriday, June 30, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, April 6, 2016
Registration Number3240131
Registration DateTuesday, May 8, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and/or treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, the genitourinary system, musculo-skeletal and inflammatory disorders; or used in dermatology, oncology, hematology, opthalmology, in transplantation; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; pharmaceutical preparations for the treatment of bacteria-based diseases; anti-infectives, antivirals, antibiotics, antifungals, vaccines, and pharmaceutical preparations for diagnostic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, April 30, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events

Event DateEvent Description
Friday, October 27, 2017NOTIFICATION PROCESSED BY IB
Friday, June 30, 2017NOTIFICATION PROCESSED BY IB
Thursday, April 21, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, April 21, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, February 6, 2015NOTIFICATION PROCESSED BY IB
Tuesday, November 25, 2014CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, November 14, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Sunday, May 19, 2013NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, May 18, 2013DEATH OF INTERNATIONAL REGISTRATION
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 19, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 25, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 23, 2007FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 23, 2007FINAL DISPOSITION PROCESSED
Monday, October 15, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 8, 2007REGISTERED-PRINCIPAL REGISTER
Wednesday, May 2, 2007ASSIGNED TO EXAMINER
Tuesday, February 20, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 31, 2007NOTICE OF PUBLICATION
Friday, December 22, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 22, 2006REFUSAL PROCESSED BY IB
Thursday, December 21, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 6, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 6, 2006REFUSAL PROCESSED BY MPU
Tuesday, December 5, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, December 4, 2006ASSIGNED TO LIE
Monday, December 4, 2006EXAMINER'S AMENDMENT ENTERED
Monday, December 4, 2006EXAMINERS AMENDMENT E-MAILED
Monday, December 4, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, December 4, 2006NON-FINAL ACTION WRITTEN
Saturday, December 2, 2006ASSIGNED TO EXAMINER
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 8, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, September 7, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

risarg system preparations pharmaceutical disorders treatment diseases prevention enterology ocular bacteria